Is Neuroblastoma a Genetic Disorder?

Li Liu, MD
Last Modified: November 1, 2001

Dear OncoLink "Ask the Experts,"
Is neuroblastoma a genetic disorder?

Li Liu, MD, OncoLink Editorial Assistant, responds:

Dear K,
Thank you for your interest and question.

Neuroblastoma is the most common malignant intraabdominal tumor in children. It constitutes 7-10% of all cases of childhood cancer. While its etiology remains unknown, there may be genetic factors, which predispose to its development. Evidence for this comes from two fronts. First, neuroblastoma has been reported in the medical literature (Cancer 57:1887, 1986; European Journal of Pediatrics, 150:789, 1991). However, this is very rare. Second, chromosomal abnormalities have been reported as a possible predisposing factor to the development of neuroblastoma (Genes Chromosomes Cancers 2:252, 1990). Almost all neuroblastoma tumors demonstrate activation of the N-myc oncogene (inappropriate activation of oncogenes may cause cancer formation). However, how the N-myc oncogene becomes activated in the case of neuroblastoma is unclear.

Finally, the incidence of neuroblastoma appears to be higher in Caucasians than in blacks (Int J Cancer 1992 Oct 21; 52(4): 538-43), and this appears to be a worldwide phenomenon. The fact that it is a disease rarely seen in children born with Down Syndrome (Cancer Res 1998 Feb 1; 58(3): 448-52) and that Down Syndrome is rarely seen in neuroblastoma patients is further support for some genetic connection.

So while neuroblastoma is not considered a genetic disorder per se, there is evidence that some genetic factors are associated with the disease.


Survivorship Benefits of Proton Therapy
by OncoLink Editorial Team
June 17, 2015

7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Surgery Doesn't Up Pediatric Neuroblastoma Outcomes

Jan 17, 2013

Extent of first or best surgery has no impact on overall, event-free, progression-free survival

Findings Uncover Genetic Links Involved In Neuroblastoma

Nov 29, 2015

One of two new studies highlights contributor to etiology of aggressive form of childhood cancer

Genetics Linked to Variations in Treatment Response

Nov 29, 2015

Gene variations may explain patient differences in response to acute lymphoblastic leukemia therapy